Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

NCT04531813 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypersensitivity

Interventions

DRUG: Butenafine HCl 1% (BAY1896425)
DRUG: Positive Control-Sodium lauryl sulfate (SLS)
OTHER: Negative Control

Sponsor

Bayer